prophylactic vaccine (METAVAX/HepSeeVaxDelta3) (ARTES/Burnet)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameprophylactic vaccine (METAVAX/HepSeeVaxDelta3) (ARTES/Burnet)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHuman papillomavirus regulatory protein E2 modulators
TargetsHuman papillomavirus regulatory protein E2
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArtes Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArtes BiotechnologyThe Macfarlane Burnet Institute For Medical Research And Public Health Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A